The Board of McPherson's Limited confirms the resignation of Grant Peck, Managing Director, effective 31 May 2023. The Company's search for a new Managing Director currently continues. As an interim measure, the Company announces that the non-executive Chair, Ari Mervis, will assume the role of Executive Chair and that non-executive Director Alison Cook will assume the role of Chief Operating Officer, both effective 1 June 2023.

Alison will take responsibility for the operating activities of the business, reporting to Ari through the Board as appropriate. The Company's senior leadership team will report to Alison. Alison has been a Director of the Company since July 2018.

She has over 30 years of management and leadership experience across the biopharmaceutical, diagnostic and health service sectors, as Chief Operating Officer then CEO of Genetic Technologies Ltd, an ASX and NASDAQ listed leading edge genetic testing services business. She also has 13 years' experience with CSL Ltd. in senior executive positions. Alison brings a high-level strategic view, while also implementing practical, operational solutions.

She holds a Master of Science (Microbiology), has completed the Executive Development Program of the Melbourne Business School and is a graduate of the AICD Company Directors Course. Alison will continue as a non-executive director once her interim role as COO is concluded, and Ari will revert to non-executive Chair.